About Cryoport
Cryoport is a publicly listed company based in Brentwood (United States) founded in 2019. It operates as a supply chain solutions for cell and gene therapies are provided. It operates on a Managed Services and Direct-to-Consumer (D2C) model. The company has 1,190 employees. Its chief executive is Jerrell W Shelton. Cryoport offers products and services including Cryogenic Storage Systems, Temperature-Controlled Supply Chain Solutions, and Biostorage and Sample Processing. Its focus areas include Biotechnology and Cell & Gene Therapy. Its legal entity is Cryoport, Inc. Its competitors include GenVault Corporation, iSpecimen, PrecisionMed, Cryoniss and AminoChain and 3 more; 6 of its 8 listed competitors have raised funding.
Company details
Cryoport, Inc. is established as a key player in the life sciences sector, specializing in temperature-controlled supply chain solutions. The company is known as the worlds largest manufacturer of cryogenic storage systems. It is also a leader in supporting clinical trials and commercial therapies for regenerative medicine. Additionally, trusted biostorage and sample processing services are provided. Operations span across the Americas, EMEA, and APAC regions with over 15 locations worldwide. Services are extended to biopharmaceutical, animal husbandry, and reproductive medicine companies, as well as universities, research institutions, and government agencies. Innovative supply-chain technologies and services are delivered through industry-leading brands like Cryoport Systems, MVE Biological Solutions, and CRYOGENE.
- Headquarters Brentwood, United States
- Employees 1,190
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website cryoportinc.com
- Social LinkedIn X YouTube
- Legal Name Cryoport, Inc.
- Annual Revenue$176.18 M (USD)12.38as on Dec 31, 2025
- Net Profit-$38.65 M (USD)66.32as on Dec 31, 2025
- EBITDA-$16.79 M (USD)52.68as on Dec 31, 2025
- Employee Count1,190
Products & Services of Cryoport
Cryoport offers a comprehensive portfolio of products and services, including Cryogenic Storage Systems, Temperature-Controlled Supply Chain Solutions, and Biostorage and Sample Processing.
Cryogenic storage systems are manufactured for life sciences.
Temperature-controlled solutions are provided for life sciences.
Biostorage and processing services are offered for research.
Apps and channels of Cryoport
its YouTube channel Cryoport has 17 subscribers and 21 videos.
Videos from Cryoport
The most watched videos on Cryoport's YouTube channel, Cryoport (17 subscribers). Click a video to play it here.
More on Cryoport.
People of Cryoport
1 people are tracked at Cryoport (1 in leadership); the tracked headcount is 1,190.
| Name | Role | Group |
|---|---|---|
Jerrell W Shelton | CEO | Leadership |
Complete people profiles for Cryoport
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Cryoport
Cryoport is a publicly listed company on the NASDAQ with ticker symbol CYRX in USA, operating in the Transportation sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date05 Jan 2009
- Listed onNASDAQ: CYRX
- Listed entityCryoPort, Inc.
- Exchange sectorTransportation
- ISINUS2290503075
- Share price$16.95 (+0.65% on the day) · 2026-10-13
- Market capitalisation$858.5M
- EPS (diluted, trailing year)$-0.82
- Volume (last session)575,584
Financials of Cryoport
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $176.2M | -$38.6M | -$16.8M |
| 2024 | $156.8M | -$114.8M | -$35.5M |
| 2023 | $233.2M | -$99.6M | -$31.2M |
| 2022 | $237.3M | -$37.3M | -$7.0M |
| 2021 | $222.6M | -$275.5M | $6.8M |
Detailed financial statements for Cryoport
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Cryoport
Cryoport has 8 listed competitors in our database, 6 of them funded. They include GenVault Corporation, iSpecimen, PrecisionMed, Cryoniss and AminoChain, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genvault.com | 2000 | Carlsbad, United States | $47.8M | – | Biosamples are stabilized, transported, stored, and retrieved by GenVault. | |
| ispecimen.com | 2009 | Lexington, United States | $11.86M | 75 | Provider of a biorepository of human clinical specimens | |
| precisionmed.com | 1996 | San Diego, United States | – | – | Human biological materials for research are supplied via a biorepository. | |
| cryoniss.com | 2018 | Macclesfield, United Kingdom | $683,055 | 9 | Provider of biobanking services for life sciences industries | |
| aminochain.io | 2022 | New York, United States | $7.07M | – | A blockchain-based platform for tokenizing and incentivizing stem cell donations | |
| viacellinc.com | 1994 | Cambridge, United States | $63M | – | Provider of services for collecting and preserving umbilical cord blood stem cells | |
| indivumed.com | 2002 | Hamburg, Germany | – | 178 | Biospecimens are collected, preserved, and analyzed for oncology services. | |
| biostorage.com | 2002 | Indianapolis, United States | $8.77M | – | Provides bio repository services |
Detailed competitors of Cryoport
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cryoport
The website of Cryoport (cryoportinc.com) receives about 3.4K visits a month.
- Monthly visits3.4K
▼ 6.1% vs previous month
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as Cryoport (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cryoport
Complete news archive for Cryoport
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cryoport
Cryoport was founded in 2019.
Cryoport is headquartered in Brentwood, United States.
Jerrell W Shelton is the current CEO of Cryoport.
Cryoport has 1,190 employees.
Annual revenue of Cryoport is $176.18M as on Dec 31, 2025.
Cryoport, Inc. is established as a key player in the life sciences sector, specializing in temperature-controlled supply chain solutions. The company is known as the worlds largest manufacturer of cryogenic storage systems. It is also a leader in supporting clinical trials and commercial therapies for regenerative medicine. Additionally, trusted biostorage and sample processing services are provided. Operations span across the Americas, EMEA, and APAC regions with over 15 locations worldwide. Services are extended to biopharmaceutical, animal husbandry, and reproductive medicine companies, as well as universities, research institutions, and government agencies. Innovative supply-chain technologies and services are delivered through industry-leading brands like Cryoport Systems, MVE Biological Solutions, and CRYOGENE.
Cryoport's top competitors include iSpecimen, AminoChain and GenVault Corporation.
Cryoport offers Cryogenic Storage Systems, Temperature-Controlled Supply Chain Solutions, and Biostorage and Sample Processing.
Yes, Cryoport is publicly traded on NASDAQ under the ticker symbol CYRX.
Cryoport operates through Cryoport, Inc..